NCT02143440Unknown不适用
The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 65
- 试验地点
- 1
- 主要终点
- When the glucose level decreased to about 10 mmol/L
研究概览
简要总结
To investigate the daily dose of insulin in newly diagnosed Chinese type 2 diabetic patients who use the continuous subcutaneous insulin infusion (CSII) as the initial therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All participants with type 2 diabetes, diagnosed by World Health Organization criteria, were recruited from outpatient of the Endocrinology Department in Shanghai Renji Hospital.
排除标准
- •Patients who had a history of coronary heart disease, abnormal renal function, active liver disease, chronic metabolic acidosis (including diabetic ketoacidosis), or severe chronic gastrointestinal disease.
结局指标
主要结局
When the glucose level decreased to about 10 mmol/L
时间窗: 72-96 hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Insulin Dose Titration System Using a Short Messaging Service (SMS) Automatically Produced by a Knowledge MatrixDiabetes Mellitus, Type 2NCT00948584Hallym University Medical Center100
已完成
不适用
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitusJPRN-UMIN000011287General incorporated Tokyo Physicians Association.100
Unknown
不适用
A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily InjectionsDiabetes Mellitus Type 1NCT01045954Diabetes Care Center50
已完成
3 期
A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take InsulinDiabetes Mellitus, Type 2NCT04233801Boehringer Ingelheim219
撤回
1 期
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02623465Eli Lilly and Company